Related Experiment Video
Updated: Apr 13, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Changes in the pattern of paracetamol use in the periconception period in a Danish cohort
Anne S Ersbøll1,2, Mette Hedegaard1,2, Peter Damm2,3
1Research Unit, Women's and Children's Health, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Insights
Paracetamol is a common pregnancy medication. Frequent use before and during early pregnancy was linked to factors like smoking and unplanned pregnancies, with usage decreasing after legislation restricted large pack access.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
- Public Health
Background:
- Paracetamol (acetaminophen) is a widely used over-the-counter medication during pregnancy.
- While generally considered safe, prolonged antenatal exposure is linked to potential offspring morbidity.
- Understanding usage patterns, especially frequent use, is crucial for maternal and child health.
Purpose of the Study:
- To characterize paracetamol (acetaminophen) consumption patterns in pregnant women.
- To identify factors associated with frequent paracetamol use (more than once weekly) before and during early pregnancy.
- To evaluate the impact of legislation restricting large pack access on paracetamol usage.
Main Methods:
- A web-based clinical questionnaire administered to 8650 pregnant women.
- Data collected on drug use, including paracetamol, in the 3 months prior to and during early pregnancy.
- Statistical analysis to identify associations between frequent paracetamol use and demographic/clinical factors.
Main Results:
- Paracetamol was the most frequently used drug, with 35.2% use before pregnancy and 6.5% during early pregnancy.
- The proportion of frequent paracetamol users decreased from 3.9% pre-pregnancy to 0.9% in early pregnancy.
- Frequent use was associated with smoking, comorbidities, higher BMI, unplanned pregnancy, lower education, and language barriers. Legislation restricting large pack access correlated with a decrease in overall paracetamol use.
Conclusions:
- Paracetamol is commonly used by pregnant women, but frequent use is less common and associated with specific risk factors.
- Legislation limiting access to large paracetamol packs may reduce overall usage during pregnancy.
- Further research into the specific risks of frequent antenatal paracetamol exposure is warranted.
Abstract:
Paracetamol is the most commonly used over-the-counter drug in pregnancy. It is generally considered to be safe, but prolonged antenatal exposure has been associated with offspring short- and long-term morbidity. Our aim was to describe the pattern of paracetamol use with a focus on frequent ingestion (more than once a week), 3 months before and in early pregnancy. In this cohort, 8650 pregnant women responded to a web-based clinical questionnaire that included questions about drug use. Paracetamol was the most used drug before and in early pregnancy (35.2% and 6.5% of respondents, respectively). The proportion of frequent users decreased from 3.9% before to 0.9% in early pregnancy. Frequent paracetamol use was associated with smoking, co-morbidities, body mass index ≥ 25 kg/m(2), unplanned pregnancy, no education and inability to understand Danish. A significant decrease in the proportion of women with any paracetamol use in early pregnancy was noted after access to large packs was restricted by legislation.
More Related Videos
11:08The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
Published on: March 13, 2014
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Factors Affecting Drug Response: Overview
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Analysis of Population Pharmacokinetic Data